TherapeuticsMD (TXMD) EBITDA (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly EBITDA came in at -$723000.0 in Q1 2026, up 43.56% YoY from -$503623.2 in Q1 2025, and up 53.41% on a QoQ basis from -$1.6 million in Q4 2025.
TherapeuticsMD (TXMD) EBITDA (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of EBITDA data on file, last reported at -$723000.0 in Q1 2026.
- Quarterly EBITDA rose 43.56% year-over-year to -$723000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.8 million (up 34.56% YoY) and the FY2025 annual result came in at -$4.4 million, up 28.17% from the prior year.
- EBITDA climbed to -$723000.0 in Q1 2026, from -$1.6 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $48.4 million in Q4 2022 to a low of -$17.5 million in Q1 2022.
- A 5-year average of -$999588.2 and a median of -$1.6 million in 2025 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2022 — EBITDA soared 236.87% — and 2025, when it slumped 138.04%.
- Tracing TXMD's EBITDA over 5 years: stood at $48.4 million in 2022, then plunged by 103.33% to -$1.6 million in 2023, then jumped by 59.53% to -$652000.0 in 2024, then tumbled by 138.04% to -$1.6 million in 2025, then soared by 53.41% to -$723000.0 in 2026.
- The last three EBITDA figures came in at -$723000.0 (Q1 2026), -$1.6 million (Q4 2025), and -$862000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.67 Mn | 14.48 Mn | - | -816,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -816,000.00 |
| Mar 31, 2026 | -723,000.00 |
| Dec 31, 2025 | -1.55 Mn |
| Sep 30, 2025 | -862,000.00 |
| Jun 30, 2025 | -695,000.00 |
| Mar 31, 2025 | -1.28 Mn |
| Dec 31, 2024 | -652,000.00 |
| Sep 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | -2.79 Mn |
| Mar 31, 2024 | -1.14 Mn |
| Dec 31, 2023 | -1.61 Mn |
| Sep 30, 2023 | -1.64 Mn |
| Jun 30, 2023 | -2.34 Mn |
| Mar 31, 2023 | -2.64 Mn |
| Dec 31, 2022 | 48.44 Mn |
| Sep 30, 2022 | -14.25 Mn |
| Jun 30, 2022 | -14.58 Mn |
| Mar 31, 2022 | -17.55 Mn |
| Dec 31, 2021 | -35.39 Mn |
| Sep 30, 2021 | -39.92 Mn |